Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Kim Rand

发表论文 12 篇 · 总被引 35 次 · h-index 3

代表论文

  • Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis (2023 · Dermatologic Therapy · 被引 17)
  • Developing an EQ-5D-5L Value Set for Singapore (2025 · PharmacoEconomics (Auckland) · 被引 15)
  • EQ-5D-5L value set for Norway: a hybrid model using cTTO and DCE data (2024 · Quality of Life Research · 被引 12)
  • Letter to the Editor Regarding “Dupilumab Versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo Adjusted Indirect Treatment Comparison” (2025 · Dermatologic Therapy · 被引 2)
  • Letter to the Editor Regarding "Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis". (2026 · Dermatologic Therapy · 被引 1)
  • Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis (2024 · Dermatologic Therapy · 被引 1)